Blood Glucose Monitoring System Market North America – Forecast (2017-2026) _ by Product (Self-Monitoring and Continuous Glucose Monitoring Systems), by Testing Site (Fingertip and Alternate Site Testing), by Patient Care Setting (Homecare and Hospital), by Application and by Geography

Blood Glucose Monitoring System Market North America – Forecast (2017-2026) _ by Product (Self-Monitoring and Continuous Glucose Monitoring Systems), by Testing Site (Fingertip and Alternate Site Testing), by Patient Care Setting (Homecare and Hospital), by Application and by Geography

Market Scenario

North America Blood Glucose Monitoring System Market is expected to reach USD XX Billion by 2026 from USD XX Billion in 2016 at a CAGR of XX% (Detailed analysis of the market CAGR is provided in the report). Blood glucose monitoring, in general, is a way of testing glucose concentration within blood, which in other words is known as glycemia. A blood glucose test is normally performed by piercing on the skin of the finger to draw blood which is applied over a chemically active test-strip. Manufacturers use different technologies for measurement, with most systems measuring electrical characteristic for determining glucose level present in the blood. A blood glucose meter is required for monitoring the glucose level, which is a small and portable machine. It is also used for measuring the type of glucose and its presence within the blood and has recently become quite cost efficient and better availability as well. People having diabetes often use a blood glucose meter to receive real-time information about their health and also help them manage their condition accordingly. North America Blood Glucose Monitoring System market Blood Glucose Monitoring System market for North America has been divided on the basis of product, testing type, patient care setting, application, and geography. Based on the product, the market has been segmented into self-monitoring and continuous monitoring systems. The self-monitoring systems accounted for the largest share with continuous monitoring growing at a high CAGR as compared to other segments. Rising incidences of patients getting directly involved with their medical treatment along with the easy availability of real-time data have resulted in more number of people opting for self-monitoring devices. By testing type, the market for blood glucose monitoring system has been divided into fingertip and alternate site testing with fingertip holding a larger market share. The traditional way of ejecting blood has been through fingertips resulting in its dominance over other segments. The growing advances in the healthcare sector have resulted in people getting more aware of their body. This trend has further led to the high demand for minimally invasive surgeries or treatments where people still prefer certain traditional medications leading to a higher market share of the fingertip. The market on the basis of patient care setting has been further segmented into homecare and hospitals. Homecare has come across as a dominant segment followed by hospitals. Cost efficiency, portability and growing awareness regarding continuous monitoring of diabetes’s have formed some important reasons that have driven overall growth. Diabetes 2 will hold the largest market share in the application segment. North America has been focused on evolutions in the healthcare sector with pharmaceutical companies opting for cost-effective solutions that may help patients suffering from diabetes. The US and Canada have both been actively working on delivering cost-effective solutions for diabetes that is expected to dominate world health care in the next 20 years. Key Highlights: • North America Blood Glucose Monitoring System market size analysis and forecast • Comprehensive study and analysis of market drivers, restraints, and opportunities influencing the growth of the North America Blood Glucose Monitoring System market • Blood Glucose Monitoring System market segmentation on the basis of product, testing type, patient care setting, application, and geography. • Blood Glucose Monitoring System market strategic analysis with respect to individual growth trends, future prospects along with a contribution of various sub-market stakeholders have been considered under the scope of a study • Blood Glucose Monitoring System market analysis and forecast for major countries has been provided. • Profiling of key industry players, their strategic perspective, market positioning and analysis of core competencies • Competitive landscape of the key players operating in the Blood Glucose Monitoring System market including competitive developments, investments, and strategic expansion Years that have been considered for the study are as follows: • Base Year – 2016 • Estimated Year – 2017 • Forecast Period – 2017 to 2026 For company profiles, 2016 has been considered as the base year. In cases, wherein information was unavailable for the base year, the years prior to it have been considered. Research Methodology: The market is estimated by triangulation of data points obtained from various sources and feeding them into a simulation model created individually for each market. The data points are obtained from paid and unpaid sources along with paid primary interviews with key opinion leaders (KOLs) in the market. KOLs from both, demand and supply side were considered while conducting interviews to get an unbiased idea of the market. This exercise was done at a country level to get a fair idea of the market in countries considered for this study. Later this country-specific data was accumulated to come up with regional numbers and then arrive at the market value for North America Blood Glucose Monitoring System market. Some of the key players of the North America Blood Glucose Monitoring System market include: • Abbott Laboratories • LifeScan • Medtronic • Dexcom • Arkay, Inc. • B. Braun Melsungen AG • Bayer Healthcare AG • Becton Dickinson • F. Hoffmann-La Roche • Novel Biomedical Corporation • Terumo Europe NV • Johnson & Johnson • Terumo Medical Corporation • Nipro Diagnostics, Inc • Novo Nordisk • Ypsomed AG • GlySens Incorporated Key Target Audience: • Blood glucose monitoring systems and related devices manufacturers • Hospitals, diagnostic centers, homecare service providers, and medical colleges • Teaching hospitals and academic medical centers • Suppliers and distributors of blood glucose monitoring systems • Government bodies or municipal corporations

Scope of the Blood Glucose Monitoring System Market Report:

The research report segments North America Blood Glucose Monitoring System market based on product, testing site, patient care setting, application and geography.

Blood Glucose Monitoring System Market, By Product:

• Self-Monitoring Blood Glucose Systems • Blood Glucose meters • Testing strips • Lancets & Lancing Devices • Continuous Glucose Monitoring Systems • Sensors • Transmitters • Receivers

Blood Glucose Monitoring System Market, By Testing Site:

• Fingertip testing • Alternate Site Testing

Blood Glucose Monitoring System Market, By Patient Care Setting:

• Self/Home Care • Hospital & Clinics

Blood Glucose Monitoring System Market, By Application:

• Type 2 Diabetes • Type 1 Diabetes • Gestational Diabetes

Blood Glucose Monitoring System Market, By Geography:

• North America • US • Canada Geographic Analysis • Breakdown of US Blood Glucose Monitoring System market • Breakdown of Canada Blood Glucose Monitoring System market Available Customization Maximize Market Research offers customization of reports according to the specific requirement of our clients. Synthetic Biology Market North America

Table of Contents

Blood Glucose Monitoring System Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: North America Blood Glucose Monitoring System Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 4.8. Patent Registration 5. Supply Side and Demand Side Indicators 6. North America Blood Glucose Monitoring System Market Analysis and Forecast 7. North America Blood Glucose Monitoring System Market Analysis and Forecast, by Product 7.1. Introduction and Definition 7.2. Key Findings 7.3. North America Blood Glucose Monitoring System Market Value Share Analysis, by Product 7.4. North America Blood Glucose Monitoring System Market Size (US$ Bn) Forecast, by Product 7.5. North America Blood Glucose Monitoring System Market Analysis, by Product 7.6. North America Blood Glucose Monitoring System Market Attractiveness Analysis, by Product 8. North America Blood Glucose Monitoring System Market Analysis and Forecast, by Testing Site 8.1. Introduction and Definition 8.2. Key Findings 8.3. North America Blood Glucose Monitoring System Market Value Share Analysis, by Testing Site 8.4. North America Blood Glucose Monitoring System Market Size (US$ Bn) Forecast, by Testing Site 8.5. North America Blood Glucose Monitoring System Market Analysis, by Testing Site 8.6. North America Blood Glucose Monitoring System Market Attractiveness Analysis, by Testing Site 9. North America Blood Glucose Monitoring System Market Analysis and Forecast, by Patient Care Setting 9.1. Introduction and Definition 9.2. Key Findings 9.3. North America Blood Glucose Monitoring System Market Value Share Analysis, by Patient Care Setting 9.4. North America Blood Glucose Monitoring System Market Size (US$ Bn) Forecast, by Patient Care Setting 9.5. North America Blood Glucose Monitoring System Market Analysis, by Patient Care Setting 9.6. North America Blood Glucose Monitoring System Market Attractiveness Analysis, by Patient Care Setting 10. North America Blood Glucose Monitoring System Market Analysis and Forecast, by Application 10.1. Introduction and Definition 10.2. Key Findings 10.3. North America Blood Glucose Monitoring System Market Value Share Analysis, by Application 10.4. North America Blood Glucose Monitoring System Market Size (US$ Bn) Forecast, by Application 10.5. North America Blood Glucose Monitoring System Market Analysis, by Application 10.6. North America Blood Glucose Monitoring System Market Attractiveness Analysis, by Application 11. North America Blood Glucose Monitoring System Market Analysis, by Region 11.1. North America Blood Glucose Monitoring System Market Value Share Analysis, by Region 11.2. North America Blood Glucose Monitoring System Market Size (US$ Bn) Forecast, by Region 11.3. North America Blood Glucose Monitoring System Market Attractiveness Analysis, by Region 12. North America Blood Glucose Monitoring System Market Analysis 12.1. Key Findings 12.2. North America Blood Glucose Monitoring System Market Overview 12.3. North America Blood Glucose Monitoring System Market Value Share Analysis, by Product 12.4. North America Blood Glucose Monitoring System Market Forecast, by Product 12.4.1. Self-Monitoring Blood Glucose Systems 12.4.1.1. Blood Glucose meters 12.4.1.2. Testing strips 12.4.1.3. Lancets & Lancing Devices 12.4.2. Continuous Glucose Monitoring Systems 12.4.2.1. Sensors 12.4.2.2. Transmitters 12.4.2.3. Receivers 12.5. North America Blood Glucose Monitoring System Market Value Share Analysis, by Testing Site 12.6. North America Blood Glucose Monitoring System Market Forecast, by Testing Site 12.6.1. Fingertip testing 12.6.2. Alternate Site Testing 12.7. North America Blood Glucose Monitoring System Market Value Share Analysis, by Patient Care Setting 12.8. North America Blood Glucose Monitoring System Market Forecast, by Patient Care Setting 12.8.1. Self/Home Care 12.8.2. Hospital & Clinics 12.9. North America Blood Glucose Monitoring System Market Value Share Analysis, by Application 12.10. North America Blood Glucose Monitoring System Market Forecast, by Application 12.10.1. Type 2 Diabetes 12.10.2. Type 1 Diabetes 12.10.3. Gestational Diabetes 12.11. North America Blood Glucose Monitoring System Market Value Share Analysis, by Country 12.12. North America Blood Glucose Monitoring System Market Forecast, by Country 12.12.1. U.S. 12.12.2. Canada 12.13. North America Blood Glucose Monitoring System Market Analysis, by Country 12.14. U.S. Blood Glucose Monitoring System Market Forecast, by Product 12.14.1. Self-Monitoring Blood Glucose Systems 12.14.1.1. Blood Glucose meters 12.14.1.2. Testing strips 12.14.1.3. Lancets & Lancing Devices 12.14.2. Continuous Glucose Monitoring Systems 12.14.2.1. Sensors 12.14.2.2. Transmitters 12.14.2.3. Receivers 12.15. U.S. Blood Glucose Monitoring System Market Forecast, by Testing Site 12.15.1. Fingertip testing 12.15.2. Alternate Site Testing 12.16. U.S. Blood Glucose Monitoring System Market Forecast, by Patient Care Setting 12.16.1. Self/Home Care 12.16.2. Hospital & Clinics 12.16.3. 12.17. U.S. Blood Glucose Monitoring System Market Forecast, by Application 12.17.1. Type 2 Diabetes 12.17.2. Type 1 Diabetes 12.17.3. Gestational Diabetes 12.18. Canada Blood Glucose Monitoring System Market Forecast, by Product 12.18.1. Self-Monitoring Blood Glucose Systems 12.18.1.1. Blood Glucose meters 12.18.1.2. Testing strips 12.18.1.3. Lancets & Lancing Devices 12.18.2. Continuous Glucose Monitoring Systems 12.18.2.1. Sensors 12.18.2.2. Transmitters 12.18.2.3. Receivers 12.19. Canada Blood Glucose Monitoring System Market Forecast, by Testing Site 12.19.1. Fingertip testing 12.19.2. Alternate Site Testing 12.20. Canada Blood Glucose Monitoring System Market Forecast, by Patient Care Setting 12.20.1. Self/Home Care 12.20.2. Hospital & Clinics 12.21. Canada Blood Glucose Monitoring System Market Forecast, by Application 12.21.1. Type 2 Diabetes 12.21.2. Type 1 Diabetes 12.21.3. Gestational Diabetes 12.22. North America Blood Glucose Monitoring System Market Attractiveness Analysis 12.22.1. By Product 12.22.2. By Testing Site 12.22.3. By Patient Care Setting 12.22.4. By Application 12.23. PEST Analysis 12.24. Key Trends 12.25. Key Developments 13. Company Profiles 13.1. Market Share Analysis, by Company 13.2. Competition Matrix 13.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 13.2.2. New Product Launches and Product Enhancements 13.2.3. Market Consolidation 13.2.3.1. M&A by Regions, Industry with Applications 13.2.3.2. M&A Key Players, Forward Integration and Backward Integration 13.3. Company Profiles: Key Players 13.3.1. Abbott Laboratories 13.3.1.1. Company Overview 13.3.1.2. Financial Overview 13.3.1.3. Product Portfolio 13.3.1.4. Business Strategy 13.3.1.5. Recent Developments 13.3.1.6. Developments Footprints 13.3.2. LifeScan 13.3.3. Medtronic 13.3.4. Dexcom 13.3.5. Arkay, Inc. 13.3.6. B. Braun Melsungen AG 13.3.7. Bayer Healthcare AG 13.3.8. Becton Dickinson 13.3.9. F. Hoffmann-La Roche 13.3.10. Novel Biomedical Corporation 13.3.11. Terumo Europe NV 13.3.12. Johnson & Johnson 13.3.13. Terumo Medical Corporation 13.3.14. Nipro Diagnostics, Inc 13.3.15. Novo Nordisk 13.3.16. Ypsomed AG 13.3.17. GlySens Incorporated 14. Primary Key Insights

Inquiry Before Buying

Request Sample

About This Report

Report ID1638
Category Healthcare
Publisher Name
No of Pages
Total Views
Published Date
Contact Us
Call Now